G. Şirin And S. Hülagü, "Ongoing Viremia at the End of Treatment With Direct Acting Antivirals could be finished as Clinical Cure in Patients with Chronic Hepatitis C: a Case Series (PP-20, s18).," TASL-EASL educational conference. , İstanbul, Turkey, 2018
Şirin, G. And Hülagü, S. 2018. Ongoing Viremia at the End of Treatment With Direct Acting Antivirals could be finished as Clinical Cure in Patients with Chronic Hepatitis C: a Case Series (PP-20, s18).. TASL-EASL educational conference. , (İstanbul, Turkey).
Şirin, G., & Hülagü, S., (2018). Ongoing Viremia at the End of Treatment With Direct Acting Antivirals could be finished as Clinical Cure in Patients with Chronic Hepatitis C: a Case Series (PP-20, s18). . TASL-EASL educational conference., İstanbul, Turkey
Şirin, GÖKTUĞ, And SADETTİN HÜLAGÜ. "Ongoing Viremia at the End of Treatment With Direct Acting Antivirals could be finished as Clinical Cure in Patients with Chronic Hepatitis C: a Case Series (PP-20, s18).," TASL-EASL educational conference., İstanbul, Turkey, 2018
Şirin, GÖKTUĞ And Hülagü, SADETTİN. "Ongoing Viremia at the End of Treatment With Direct Acting Antivirals could be finished as Clinical Cure in Patients with Chronic Hepatitis C: a Case Series (PP-20, s18).." TASL-EASL educational conference. , İstanbul, Turkey, 2018
Şirin, G. And Hülagü, S. (2018) . "Ongoing Viremia at the End of Treatment With Direct Acting Antivirals could be finished as Clinical Cure in Patients with Chronic Hepatitis C: a Case Series (PP-20, s18).." TASL-EASL educational conference. , İstanbul, Turkey.
@conferencepaper{conferencepaper, author={GÖKTUĞ ŞİRİN And author={SADETTİN HÜLAGÜ}, title={Ongoing Viremia at the End of Treatment With Direct Acting Antivirals could be finished as Clinical Cure in Patients with Chronic Hepatitis C: a Case Series (PP-20, s18).}, congress name={TASL-EASL educational conference.}, city={İstanbul}, country={Turkey}, year={2018}}